Young Kwon - Net Worth and Insider Trading
Young Kwon Net Worth
The estimated net worth of Young Kwon is at least $13 Million dollars as of 2024-12-27. Young Kwon is the Chief Financial & Bus. Officer of Momenta Pharmaceuticals Inc and owns about 160,633 shares of Momenta Pharmaceuticals Inc (MNTA) stock worth over $8 Million. Young Kwon is also the Director of ADMA Biologics Inc and owns about 241,441 shares of ADMA Biologics Inc (ADMA) stock worth over $4 Million. Details can be seen in Young Kwon's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Young Kwon has not made any transactions after 2024-08-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Young Kwon
Young Kwon Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Young Kwon owns 2 companies in total, including Momenta Pharmaceuticals Inc (MNTA) , and ADMA Biologics Inc (ADMA) .
Click here to see the complete history of Young Kwon’s form 4 insider trades.
Insider Ownership Summary of Young Kwon
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MNTA | Momenta Pharmaceuticals Inc | 2020-10-01 | Chief Financial & Bus. Officer |
| ADMA | ADMA Biologics Inc | 2024-08-23 | director |
Young Kwon Latest Holdings Summary
Young Kwon currently owns a total of 2 stocks. Among these stocks, Young Kwon owns 160,633 shares of Momenta Pharmaceuticals Inc (MNTA) as of August 10, 2020, with a value of $8 Million and a weighting of 66.12%. Young Kwon also owns 241,441 shares of ADMA Biologics Inc (ADMA) as of August 23, 2024, with a value of $4 Million and a weighting of 33.88%.
Latest Holdings of Young Kwon
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MNTA | Momenta Pharmaceuticals Inc | 2020-08-10 | 160,633 | 52.48 | 8,430,020 |
| ADMA | ADMA Biologics Inc | 2024-08-23 | 241,441 | 17.89 | 4,319,379 |
Holding Weightings of Young Kwon
Young Kwon Form 4 Trading Tracker
According to the SEC Form 4 filings, Young Kwon has made a total of 11 transactions in Momenta Pharmaceuticals Inc (MNTA) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Momenta Pharmaceuticals Inc is the sale of 652 shares on August 10, 2020, which brought Young Kwon around $21,099.
According to the SEC Form 4 filings, Young Kwon has made a total of 3 transactions in ADMA Biologics Inc (ADMA) over the past 5 years, including 2 buys and 1 sells. The most-recent trade in ADMA Biologics Inc is the sale of 60,000 shares on August 23, 2024, which brought Young Kwon around $1 Million.
Insider Trading History of Young Kwon
- 1
Young Kwon Trading Performance
GuruFocus tracks the stock performance after each of Young Kwon's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Young Kwon is 10.92%. GuruFocus also compares Young Kwon's trading performance to market benchmark return within the same time period. The performance of stocks bought by Young Kwon within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Young Kwon's insider trading performs compared to the benchmark.
Performance of Young Kwon
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 6.33 | | | | | |
| Relative Return to S&P 500(%) | 5.49 | | | | | |
Young Kwon Ownership Network
Young Kwon Owned Company Details
What does Momenta Pharmaceuticals Inc do?
Who are the key executives at Momenta Pharmaceuticals Inc?
Young Kwon is the Chief Financial & Bus. Officer of Momenta Pharmaceuticals Inc. Other key executives at Momenta Pharmaceuticals Inc include Chief Accounting Officer (PAO) Agnieszka Cieplinska , Chief Scientific Officer Anthony M. Manning , and Chief Legal Officer Alejandra Carvajal .
Momenta Pharmaceuticals Inc (MNTA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Momenta Pharmaceuticals Inc (MNTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Momenta Pharmaceuticals Inc (MNTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Momenta Pharmaceuticals Inc (MNTA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Momenta Pharmaceuticals Inc Insider Transactions
Young Kwon Mailing Address
Above is the net worth, insider trading, and ownership report for Young Kwon. You might contact Young Kwon via mailing address: C/o Momenta Pharmaceuticals Inc., 675 West Kendall Street, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
